| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |